FFC#3/2017

Optimization of a new lead promoting the readthrough of nonsense mutations for the CFTR rescue in human CF cells

FFC#3/2017

Optimization of a new lead promoting the readthrough of nonsense mutations for the CFTR rescue in human CF cells

PRINCIPAL INVESTIGATOR

Laura Lentini (Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche, Sez. Biologia Cellulare, Università degli Studi di Palermo)

Partner

Ivana Pibiri (Dip. di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche, Sez. Biochimica, Università degli Studi di Palermo)

RESEARCHERS

7

CATEGORY

AREA 1 Therapies to correct the underlying defect

DURATION

2 years

GOAL

€ 57.000 €

RESULTS

After virtual screening, we synthesized a small library of analogues of the NV2445 molecule and tested them by FLuc assay and in different biological models. These new compounds showed high read-through capacity and CFTR rescue. Moreover, in vitro and in vivo toxicity test (Zebrafish) was performed to assess the safety profile of the molecules synthesized: one of them resulted without toxicity.


Congress abstracts

  • Lentini, Melfi R, Tutone M et al. Identification of a new molecule with readthrough activity to rescue CFTR protein function, 5° meeting biotecnologie, ricerca di base, interdisciplinare, traslazionale in ambito biomedico, Palermo, 5-6 luglio 2018
  • Lentini L, Pibiri I, Melfi R. Rescue of nonsense mutations by novel readthrough molecules in biological model systems and in cystic fibrosis cells, Convegno AGI, 7-9 Settembre 2017, Cortona
  • Pibiri, Lentini L, Tutone M et al. Rescuing CFTR Protein Function: 1,3,4-oxadiazoles versus 1,2,4-oxadiazoles as readthrough inducing drugs, Italian-Spanish-Portuguese joint Meeting in Medicinal Chemistry MedChemSicily, Palermo 17-18 Luglio 2018
  • Lentini L. Rescuing mutant CFTR in cystic fibrosis by genetic drugs, XIII Summer School on Advanced Biotechnology, Orto Botanico, Palermo, 2-5 Settembre 2018
  • Campofelice A, Culletta G, Tutone M et al. Uno studio comparativo in silico sui possibili target di Ataluren e analoghi farmaci promotori di readthrough di codoni di stop prematuri, Convegno congiunto delle Sezioni di Calabria e Sicilia 2019. Palermo, 1-2 marzo 2019
  • Pibiri I, Pace A, Tutone M et al. Derivati ossadiozolici per il trattamento della fibrosi cistica: readthrough di mutazioni nonsense, Convegno congiunto delle Sezioni di Calabria e Sicilia 2019. Palermo, 1-2 marzo 2019
  • Campofelice A, Ricco Galluzzo P, Lentini L et al. New molecules as translational readthrough promoters of nonsense mutations: rescuing the CFTR protein, XXXIX Convegno nazionale della Divisione di Chimica Organica della Società Chimica Italiana, Torino, 8-12 settembre 2019
  • Campofelice A, Ricco Galluzzo P, Lentini L et al. New molecules as translational readthrough promoters of nonsense mutations: rescuing the CFTR protein, XXXIX Convegno Nazionale della Divisione di Chimica Organica, CDCO, 8-12 settembre 2019, Torino

OTHER RESULTS

FFC #3/2024

Two molecules are effective in activating Heat Shock Proteins and enhancing the action of CFTR correctors with the F508del mutation in vitro.

FFC#5/2024

Some peptide nucleic acids (PNAs) re-sensitise Pseudomonas aeruginosa to the antibiotic meropenem in vitro and reduce its virulence.

FFC#1/2023

Tezacaftor, one of the components of Kaftrio, induces an accumulation of dihydroceramides both in vitro and in vivo in animal models